Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
171.97
+7.25 (4.40%)
Jun 6, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Jan '22 2012 - 2020
Healthcare
1.43B
Log In
Log In
Log In
Log In
Upgrade
Healthcare Growth
12.48%
Log In
Log In
Log In
Log In
Upgrade
Non-Healthcare
-
Log In
Log In
Log In
Log In
Upgrade
Non-Healthcare Growth
-
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Jan '22 2012 - 2020
Healthcare Gross Profit
897.20M
Log In
Log In
Log In
Log In
Upgrade
Healthcare Gross Profit Growth
10.74%
Log In
Log In
Log In
Log In
Upgrade
Non-Healthcare Gross Profit
-
Log In
Log In
Log In
Log In
Upgrade
Non-Healthcare Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Segment Gross Profit
-91.30M
Log In
Log In
Log In
Log In
Upgrade
Other Segment Gross Profit Growth
-97.92%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 2011 - 2019
United States
Log In
Log In
Log In
Log In
Upgrade
United States Growth
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle East and Africa
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle East and Africa Growth
Log In
Log In
Log In
Log In
Upgrade
Asia and Australia
Log In
Log In
Log In
Log In
Upgrade
Asia and Australia Growth
Log In
Log In
Log In
Log In
Upgrade
North and South America (excl. U.S.)
Log In
Log In
Log In
Log In
Upgrade
North and South America (excl. U.S.) Growth
Log In
Log In
Log In
Log In
Upgrade